Literature DB >> 19078675

Peripheral nervous system manifestations of lyme borreliosis.

Pariwat Thaisetthawatkul1, Eric L Logigian.   

Abstract

Lyme disease is a tick-borne illness that has protean neurologic manifestations involving both the central and peripheral nervous system. The peripheral nervous system manifestations of Lyme borreliosis can be divided chronologically into acute and chronic forms. Within weeks after disease onset, approximately 15% of untreated patients develop an acute Lyme meningoradiculoneuritis with headache, fever, radicular pain, weakness, and sensory loss, often associated with cranial neuropathy, usually facial palsy. Cerebrospinal fluid typically shows lymphocytic pleocytosis, high protein, and normal glucose. Diagnosis is made by recognition of characteristic clinical features with a history of preceding exposure and confirmed by serologic evidence of exposure to B. burgdorferi or by antibody or PCR evidence of cerebrospinal fluid infection. Months to years after onset, rare patients may develop chronic polyradiculoneuropathy presenting with sensory symptoms or radicular pain. Diagnosis is confirmed by a history of exposure, previous systemic or acute neurologic manifestations of Lyme borreliosis, and serologic evidence of infection. Pathology of acute or chronic Lyme radiculoneuropathy reveals axonal degeneration with perivascular mononuclear infiltration. Eradication of the organism can be achieved with 2 to 4 weeks of ceftriaxone for both acute and chronic Lyme neuroborreliosis. Isolated facial palsy without evidence of cerebrospinal fluid infection can be treated with oral antibiotics such as doxycycline. Prognosis after therapy is good, but neurologic recovery is slower for chronic than acute Lyme radiculoneuropathy.

Entities:  

Year:  2002        PMID: 19078675     DOI: 10.1097/00131402-200206000-00006

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  6 in total

Review 1.  Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Authors:  Daniel J Cameron; Lorraine B Johnson; Elizabeth L Maloney
Journal:  Expert Rev Anti Infect Ther       Date:  2014-07-30       Impact factor: 5.091

2.  Peripheral facial palsy as an initial symptom of Lyme neuroborreliosis in an Austrian endemic area.

Authors:  Wolfgang Kindler; Hubert Wolf; Katrin Thier; Stefan Oberndorfer
Journal:  Wien Klin Wochenschr       Date:  2015-01-10       Impact factor: 1.704

3.  The Lyme disease bacterium, Borrelia burgdorferi, stimulates an inflammatory response in human choroid plexus epithelial cells.

Authors:  Derick Thompson; Jordyn Sorenson; Jacob Greenmyer; Catherine A Brissette; John A Watt
Journal:  PLoS One       Date:  2020-07-09       Impact factor: 3.240

Review 4.  Host transcriptome response to Borrelia burgdorferi sensu lato.

Authors:  Derick Thompson; John A Watt; Catherine A Brissette
Journal:  Ticks Tick Borne Dis       Date:  2020-12-13       Impact factor: 3.744

5.  Anti-inflammatory effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in neuronal cultures of dorsal root ganglia and myelinating cells of the peripheral nervous system.

Authors:  Geeta Ramesh; Olivia C Meisner; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2015-12-23       Impact factor: 8.322

6.  Confirmed cases of Neuroborreliosis with involvement of peripheral nervous system: Description of a cohort.

Authors:  Anne-Laure Kaminsky; Thierry Maisonobe; Timothée Lenglet; Dimitri Psimaras; Rabab Debs; Karine Viala
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.